SCHEMBL23939063

SCHEMBL23939063

CN(C1C(=O)NC(=O)C(O)(O)C1(O)O)C(O)(O)c1c(C=O)cccc1NC(O)(O)c1ccc(C(O)(O)N2CCOCC2)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281365 0.86 — —
SCHEMBL21281361 0.82 — —
SCHEMBL21281367 0.77 WDR5 (0.32) —
SCHEMBL21281566 0.75 — —
SCHEMBL21281364 0.69 — —
SCHEMBL21281559 0.69 WDR5 (0.32) —
SCHEMBL23938876 0.69 — —
SCHEMBL23939088 0.69 — —
SCHEMBL21924068 0.68 — —
SCHEMBL21281330 0.67 CRBN (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2021-10-20 — — EP disclosed
Send feedback